# Hydralazine

## Apresoline 50mg

| 藥物代碼           | OAPR5                                                                                                                                                                                                                                     |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Hypertension，為周邊血管擴張劑(A030879100)                                                                                                                                                                                                |
| 副作用             | Tachycardia, palpitation, anginal symptoms, flushing, headache, dizziness, nasal congestion, GI disturbances.                                                                                                                             |
| 禁忌               | Idiopathic SLE & related diseases. Severe tachycardia & heart failure with high cardiac output. Myocardial insufficiency due to mechanical obstruction. Right ventricular heart failure due to pulmonary HTN. Dissecting aortic aneurysm. |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                      |
| 用法用量           | Adult: 10-50 mg qid (max. dose 200-300 mg/day). Child: 0.75 mg/kg/day in 4 divided doses, up to 7.5 mg/kg/day.                                                                                                                            |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                              |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                              |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                            |
| 孕期用藥建議       | Human data suggest risk in 3rd trimester                                                                                                                                                                                                  |
| 附帶說明           | No reports linking the use of hydralazine with congenital defects have been located. However, fetal toxicity has been associated with use of the drug in the 3rd trimester.                                                               |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                       |
| 附帶說明           | N/A                                                                                                                                                                                                                                       |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                       |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                       |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                       |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                       |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                       |
| 注意事項           | N/A                                                                                                                                                                                                                                       |

